Abstract
Background
Obesity has been reported to be a prognostic factor for many diseases in epidemiological studies; however, the results of studies examining the relationship between obesity and gastric cancer (GC) prognosis are inconsistent.
Methods
A total of 460 patients with Stage II and III GC who underwent open R0 gastrectomy were included. Age, sex, body mass index (BMI classified into < 18.5, 18.5–25, and ≥ 25 kg/m2), stage, and postoperative adjuvant chemotherapy were analyzed to investigate the correlation with relapse-free survival (RFS).
Results
Five-year RFS was 51% for the study patients. Five-year RFS values were 47.6%, 54.3%, and 40.1% for patients with BMI < 18.5, 18.5–25, and ≥ 25 kg/m2, respectively. The forest plot for relapse risk according to BMI showed a U shape. Multivariate analysis for RFS showed significant differences in stage and BMI; the hazard ratio for recurrence in patients with BMI ≥ 25 kg/m2 was 1.42 (95% confidence interval: 1.01–2.02, p = 0.0423) with reference to patients with BMI < 25 kg/m2. BMI ≥ 25.0 was associated with longer operation times, more blood loss, fewer lymph nodes dissected, more frequent postoperative surgical site infection, and intra-abdominal abscesses.
Conclusions
BMI ≥ 25 kg/m2 is an unfavorable prognostic factor for patients who underwent gastrectomy for Stage II and III GC.
Similar content being viewed by others
References
Risk Factor Collaboration (NCD-RisC) NCD (2016) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 387(10026):1377–1396
Prospective Studies Collaboration (2009) Body-mass index and cause-specific mortality in 900000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083–1096
Berrington de Gonzalez A, Hartge P, Cerhan JR (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363:2211–2219
Zheng W, McLerran DF, Rolland B (2011) Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 364:719–729
Tao W, Lagergren J (2013) Clinical management of obese patients with cancer. Nat Rev Clin Oncol 10:519–533
Lavie CJ, Osman AF, Milani RV (2003) Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91:891–894
Adams KF, Schatzkin A, Harris TB (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778
Mullen JT, Moorman DW, Davenport DL (2009) The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 250:166–172
Yasunaga H, Horiguchi H, Matsuda S (2013) Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg 100:1335–1343
Ferlay J, Soerjomataram I, Dikshit R (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
Wu XS, Wu WG, Li ML (2013) Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 19(28):4596–4606
Voglino C, Di Mare G, Ferrara F (2015) Clinical and oncological value of preoperative BMI in gastric cancer patients: a single center experience. Gastroenterol Res Pract 2015:810134
Wada T, Kunisaki C, Ono HA (2015) Implications of BMI for the prognosis of gastric cancer among the Japanese population. Dig Surg 32(6):480–486
Ejaz A, Spolverato G, Kim Y (2015) Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. J Surg Res 195(1):74–82
Liu BZ, Tao L, Chen YZ (2016) Preoperative body mass index, blood albumin and triglycerides predict survival for patients with gastric cancer. PLoS ONE 11(6):e0157401
Migita K, Takayama T, Matsumoto S (2016) Impact of being underweight on the long-term outcomes of patients with gastric cancer. Gastric Cancer 19(3):735–743
Jun DH, Kim BJ, Park JH (2016) Preoperative body mass index may determine the prognosis of advanced gastric cancer. Nutr Cancer 68(8):1295–1300
Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20(1):1–19
WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163
Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14(2):101–112
Jiang X, Hiki N, Nunobe S (2012) Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107(2):275–279
Murakami Y, Saito H, Kono Y (2018) Combined analysis of the preoperative and postoperative prognostic nutritional index offers a precise predictor of the prognosis of patients with gastric cancer. Surg Today 48(4):395–403
Kuroda D, Sawayama H, Kurashige J (2018) Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer 21(2):204–212
Gunderson CC, Java J, Moore KN (2014) The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 133(1):23–27
Steffens S, Ringe KI, Schroeer K (2013) Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study. Int J Urol 20(6):585–592
Tokunaga M, Hiki N, Fukunaga T (2009) Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol 16:3245–3251
Chen HN, Chen XZ, Zhang WH (2015) The impact of body mass index on the surgical outcomes of patients with gastric cancer A 10-year, single-institution cohort study. Medicine 94(42):e1769
Kulig J, Sierzega M, Kolodziejczyk P (2010) Implications of overweight in gastric cancer: a multicenter study in a Western patient population. Eur J Surg Oncol 36:969–976
Lin YS, Huang KH, Lan YT (2013) Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery. J Gastrointest Surg 17:1382–1391
Wong J, Rahman S, Saeed N (2014) Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience. J Gastrointest Surg 18:505–511
Ejaz A, Spolverato G, Kim Y (2015) Impact of body mass index on perioperative outcomes and survival after resection for gastric cancer. J Surg Res 195:74–82
Wu XS, Wu WG, Li ML (2013) Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 19:4596–4606
Wu XS, Wu WG, Li ML (2013) Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis. World J Gastroenterol 19:4596–4606
Bickenbach KA, Denton B, Gonen M (2013) Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol 20(3):780–787
Struecker B, Biebl M, Dadras M (2017) The impact of obesity on outcomes following resection for gastric cancer. Dig Surg 34(2):133–141
Tanaka K, Miyashiro I, Yano M (2009) Accumulation of excess visceral fat is a risk factor for pancreatic fistula formation after total gastrectomy. Ann Surg Oncol 16(6):1520–1525
Sugisawa N, Tokunaga M, Tanizawa Y (2012) Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer 15(2):206–212
Takeuchi M, Ishii K, Seki H (2016) Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study. BMC Surg 16(1):54
Sorensen LT, Hemmingsen U, Kallehave F (2005) Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg 241:654–658
Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117:1219–1222
Goldfarb Y, Sorski L, Benish M (2011) Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 253:798–810
Hayashi T, Yoshikawa T, Aoyama T (2015) Impact of infectious complications on gastric cancer recurrence. Gastric Cancer 18(2):368–374
Fujiya K, Tokunaga M, Mori K (2016) Long-term survival in patients with postoperative intra-abdominal infectious complications after curative gastrectomy for gastric cancer: a propensity score matching analysis. Ann Surg Oncol 23(Suppl 5):809–816
Vuong B, Graff-Baker AN, Dehal A (2017) Survival analysis with extended lymphadenectomy for gastric cancer: removing stage migration from the equation. Am Surg 83(10):1074–1079
Biondi A, D’Ugo D, Cananzi FC (2015) Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncol 41(6):779–786
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kambara, Y., Yuasa, N., Takeuchi, E. et al. Overweight or Obesity is an Unfavorable Long-Term Prognostic Factor for Patients who Underwent Gastrectomy for Stage II/III Gastric Cancer. World J Surg 43, 1766–1776 (2019). https://doi.org/10.1007/s00268-019-04969-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-019-04969-1